Madrigal Pharmaceuticals, Inc.

MDGL

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001157601

SEC filings (opens in a new tab)

In the last 90 days, Madrigal Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 3 sales; 414 institutions reported holding it in 13F filings for Q2 2026, worth $12.7B in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding Madrigal Pharmaceuticals, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022 All holders in Q1 2022

13F holders of MDGL: Q1 2022 compared with Q2 2022
Measure	Q1 2022	Of which not filed for Q2 2022	Q2 2022	Change
Holders	140	4	138	+2
Shares	12.3M	22.8K	12.0M	−230.1K (−1.9%)
Value	$1.20B	$2.24M	$857.7M	−$335.1M (−28.1%)

4 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (24)

Institutions that held Madrigal Pharmaceuticals, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to MDGL in Q2 2022
Institution	Shares	Value	% of portfolio
Jennison Associates LLC	182,446	$13.1M	0.01%
Woodline Partners LP	82,176	$5.88M	0.10%
Pictet Asset Management SA	49,598	$3.55M	0.00%
MPM Oncology Impact Management LP	45,000	$3.22M	0.89%
Prudential Financial Inc	20,799	$1.49M	0.00%
Schonfeld Strategic Advisors LLC	12,347	$884.0K	0.01%
Qube Research & Technologies Ltd	10,327	$739.0K	0.01%
Assenagon Asset Management S.A.	9,209	$659.0K	0.00%
Tudor Investment Corp Et Al	7,817	$560.0K	0.02%
Group One Trading, L.P.	7,559	$541.0K	0.02%
AtonRa Partners	7,284	$521.0K	0.48%
ETF Managers Group, LLC	6,518	$469.0K	0.01%
Verition Fund Management LLC	5,340	$382.0K	0.01%
PDT Partners, LLC	4,569	$327.0K	0.03%
Millennium Management LLC	4,381	$314.0K	0.00%
Squarepoint Ops LLC	4,074	$292.0K	0.00%
ExodusPoint Capital Management, LP	3,789	$271.0K	0.00%
Dynamic Technology Lab Private Ltd	3,370	$241.0K	0.03%
Occudo Quantitative Strategies LP	3,345	$239.0K	0.02%
Virtu Financial LLC	3,273	$234.0K	0.02%
Brookfield Asset Management Inc.	3,075	$220.0K	0.00%
Amundi	1,249	$85.0K	0.00%
CoreCap Advisors, LLC	68	$5.00K	0.00%
PEAK6 Investments LLC	2,187	–	–

Sold out (22)

Institutions that held Madrigal Pharmaceuticals, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of MDGL in Q2 2022
Institution	Shares, Q1 2022	Value, Q1 2022
Adage Capital Partners GP, L.L.C.	77,331	$7.59M
Polar Asset Management Partners Inc.	52,800	$5.18M
Susquehanna International Group, LLP	22,350	$2.19M
Campbell & CO Investment Adviser LLC	13,196	$1.29M
Renaissance Technologies LLC	4,800	$471.0K
Blueshift Asset Management, LLC	4,348	$427.0K
ProShare Advisors LLC	3,976	$391.0K
LPL Financial LLC	3,768	$370.0K
Two Sigma Advisers, LP	2,982	$293.0K
SEI Investments Co	2,823	$277.0K
Teacher Retirement System of Texas	2,130	$209.0K
Clear Creek Financial Management, LLC	2,105	$207.0K
Corton Capital Inc.	2,108	$207.0K
Walleye Trading LLC	1,601	$157.0K
Aaron Wealth Advisors	12,068	$123.0K
TCI Wealth Advisors, Inc.	52	$5.00K
Ellevest, Inc.	46	$5.00K
Money Concepts Capital Corp	37	$4.00K
Cornerstone Management, Inc.	40	$3.92K
Toth Financial Advisory Corp	20	$2.00K
Fortitude Advisory Group L.L.C.	14	$1.00K
Parallel Advisors, LLC	3	$0

Not filed for Q2 2022 yet (4)

Institutions that held Madrigal Pharmaceuticals, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding MDGL in Q1 2022 that haven't filed for Q2 2022
Institution	Shares, Q1 2022	Value, Q1 2022
Parametric Portfolio Associates LLC	11,136	$1.09M
Susquehanna Fundamental Investments, LLC	6,985	$685.0K
Verity Asset Management, Inc.	2,801	$275.0K
Amalgamated Financial Corp.	1,919	$188.0K